J. Winfield, Are anti-ribosomal P protein antibodies a type of anti-lymphocyte antibody?, Clinical and Experimental Immunology, vol.109, issue.1, pp.1-3, 1997.
DOI : 10.1046/j.1365-2249.1997.00439.x

T. Mimura, P. Fernsten, W. Jarjour, and J. Winfield, Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus, Journal of Experimental Medicine, vol.172, issue.2, pp.653-659, 1990.
DOI : 10.1084/jem.172.2.653

A. Mamoune, A. Saraux, J. Delaunay, L. Goff, P. Youinou et al., Autoantibodies to CD45 in Systemic Lupus Erythematosus, Journal of Autoimmunity, vol.11, issue.5, pp.485-493, 1998.
DOI : 10.1006/jaut.1998.0225

A. Cappione, A. Pugh-bernard, J. Anolik, and I. Sanz, Lupus IgG VH4.34 Antibodies Bind to a 220-kDa Glycoform of CD45/B220 on the Surface of Human B Lymphocytes, The Journal of Immunology, vol.172, issue.7, pp.4298-307, 2004.
DOI : 10.4049/jimmunol.172.7.4298

N. Olsen, Q. Li, J. Quan, L. Wang, A. Mutwally et al., Autoantibody profiling to follow evolution of lupus syndromes, Arthritis Research & Therapy, vol.14, issue.4, 2012.
DOI : 10.1186/ar3927

H. Stafford, A. Chen, C. Anderson, A. Paul, E. Wyatt et al., Anti-ribosomal and 'P-peptide'-specific autoantibodies bind to T lymphocytes, Clinical and Experimental Immunology, vol.109, issue.1, pp.12-21, 1997.
DOI : 10.1046/j.1365-2249.1997.3691261.x

A. Mamoune, S. Kerdreux, V. Durand, A. Saraux, P. Goff et al., CD45 autoantibodies mediate neutralization of activated T cells from lupus patients through anergy or apoptosis, Lupus, vol.66, issue.8, pp.622-653, 2000.
DOI : 10.1016/0092-8674(91)90036-X

G. Kammer, Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm, Journal of Clinical Investigation, vol.115, issue.4, pp.836-876, 2005.
DOI : 10.1172/JCI24791

G. Eroglu and P. Kohler, Familial systemic lupus erythematosus: the role of genetic and environmental factors, Annals of the Rheumatic Diseases, vol.61, issue.1, pp.29-31, 2002.
DOI : 10.1136/ard.61.1.29